The effect of carvedilol on apoptosis gene PDCD5 expression in chronic heart failure patients

National Medical Journal of China

Volumn 85, Issue 10, 2005, Pages 676-678

  Wu, Yan ^a   Nie, Xiao Yun ^b   Hu, Da Yi ^b   Lu, Pi Neng ^b   Zhang, Guo Qiang ^b   Luo, Lan ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b NONE

Author keywords

Adrenergic beta antagenists; Apoptosis; Genes; Heart failure, congestive

Indexed keywords

CARVEDILOL; GENE PRODUCT; PROTEIN ANTIBODY; PROTEIN PDCD5; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DEATH; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE REGIMEN; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HUMAN; MAINTENANCE THERAPY; MALE; NAUSEA; TITRIMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARBAZOLES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROPANOLAMINES; PROSPECTIVE STUDIES;

EID: 15844364761     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Narula J, Kolodgie FD, Virmani R. Apoptosis and cardiomyopathy. Curr Opin Cardiol, 2000,15:183-188.
2. Liu H, Wang Y, Zhang Y, et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun,1999,254:203-210.
3. Chen Y, Sun R, Han W, et al. Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett,2001,509: 191-196.
4. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res, 1998,82:166-174.
5. Packer M, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med, 1996, 334: 1349-1355.
6. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001,344: 1651-1658.
7. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet,2003,362(9377): 7-13.
8. The Carvedilol Sudy Group. Carvedilol in chronic heart failure: a single-blind, randomized, placebo-controlled trial. Chin J Cardilol, 2003,31:7-10.
9. Schaper J, Lorenz-Meyer S, Suzuki K. The role of apoptosis in dilated cardiomyopathy. Herz,1999,24:219-224.